Search by Drug Name or NDC
NDC 73150-0150-06 BRIUMVI 150 mg/6mL Details
BRIUMVI 150 mg/6mL
BRIUMVI is a INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by TG Therapeutics, Inc.. The primary component is UBLITUXIMAB.
Product Information
| NDC | 73150-0150 |
|---|---|
| Product ID | 73150-150_f2a493dd-3d7e-5ecf-e053-2995a90abe22 |
| Associated GPIs | |
| GCN Sequence Number | 084247 |
| GCN Sequence Number Description | ublituximab-xiiy VIAL 150 MG/6ML INTRAVEN |
| HIC3 | H0E |
| HIC3 Description | AGENTS TO TREAT MULTIPLE SCLEROSIS |
| GCN | 53459 |
| HICL Sequence Number | 048560 |
| HICL Sequence Number Description | UBLITUXIMAB-XIIY |
| Brand/Generic | Brand |
| Proprietary Name | BRIUMVI |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ublituximab |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION, CONCENTRATE |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 150 |
| Active Ingredient Units | mg/6mL |
| Substance Name | UBLITUXIMAB |
| Labeler Name | TG Therapeutics, Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA761238 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 73150-0150-06 (73150015006)
| NDC Package Code | 73150-150-06 |
|---|---|
| Billing NDC | 73150015006 |
| Package | 1 VIAL, SINGLE-DOSE in 1 CARTON (73150-150-06) / 6 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2022-12-28 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |